{"id":"NCT01156012","sponsor":"Laboratoires Thea","briefTitle":"Efficacy and Safety Assessment of T2345 in Ocular Hypertensive or Glaucomatous Patients","officialTitle":null,"status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-09","primaryCompletion":"2010-12","completion":"2010-12","firstPosted":"2010-07-02","resultsPosted":"2014-11-19","lastUpdate":"2015-01-22"},"enrollment":404,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Glaucoma"],"interventions":[{"type":"DRUG","name":"T2345","otherNames":[]},{"type":"DRUG","name":"Prostaglandin","otherNames":[]}],"arms":[{"label":"T2345","type":"EXPERIMENTAL"},{"label":"Prostaglandin","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to assess the efficacy and safety of T2345 versus active comparator.","primaryOutcome":{"measure":"Change From Baseline in Intraocular Pressure (IOP)","timeFrame":"Day 0 and Day 84","effectByArm":[{"arm":"T2345","deltaMin":-8.6,"sd":2.6},{"arm":"Prostaglandin","deltaMin":-9,"sd":2.4}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":1,"countries":["France"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":213},"commonTop":[]}}